Short Interest in Theseus Pharmaceuticals, Inc. Increases By 43.4 percent - MarketBeat
| THRXDelisted Stock | USD 4.06 0.00 0.00% |
Slightly above 62% of Theseus Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that many traders are alarmed regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Theseus Pharmaceuticals. The current market sentiment, together with Theseus Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Theseus Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theseus Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Theseus daily returns and investor perception about the current price of Theseus Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Theseus |
Short Interest in Theseus Pharmaceuticals, Inc. Increases By 43.4 MarketBeat
Read at news.google.com
 |
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in current ratio category among related companies. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
| ELVN | Enliven Therapeutics | 7.91 | ||||
| XFOR | X4 Pharmaceuticals | 6.48 | ||||
| PMVP | Pmv PharmaceuticalsI | 6.42 | ||||
| GRTX | Galera Therapeutics | 5.56 | ||||
| IMRX | Immuneering Corp | 5.13 | ||||
| MRSN | Mersana Therapeutics | 2.98 | ||||
| TERN | Terns Pharmaceuticals | 2.84 | ||||
| CGEM | Cullinan Oncology | 2.79 | ||||
| DSGN | Design Therapeutics | 1.92 | ||||
| RCUS | Arcus Biosciences | 1.29 | ||||
| HOOK | Hookipa Pharma | 1.09 | ||||
| IPSC | Century Therapeutics | 1.00 | ||||
| GLUE | Monte Rosa | 0.89 | ||||
| LIFE | ATyr Pharma | 0.63 | ||||
| BPMC | Blueprint Medicines | 0.18 | ||||
| ERAS | Erasca | 0.47 | ||||
| RLAY | Relay TherapeuticsInc | 0.56 | ||||
| DAWN | Day One | 2.28 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world |